On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
We received an updated WNV package insert; please note the manufacturer and license number has been ...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
This is the first update to the original CTS communication distributed on July 6th. As previously co...